Intra Abdominal Pressure Measurement Devices: Understanding the Technology

 

The intra-abdominal pressure measurement devices market is primarily driven by the increasing prevalence of conditions that require critical care such as traumatic injuries, sepsis, abdominal compartment syndrome, and liver and kidney failures. Intra-abdominal pressure measurement devices are used to directly monitor intra-abdominal hypertension and abdominal compartment syndrome in critically ill patients by continuously measuring intra-abdominal pressure. The devices assist healthcare professionals in optimizing fluid management, guiding ventilator settings, and detecting complications related to elevated intra-abdominal pressure. With rising geriatric population and higher incidence of lifestyle diseases, the need for critical care is growing significantly. This, along with increasing awareness about associated complications of untreated intra-abdominal hypertension, is expected to propel the demand for intra-abdominal pressure measurement devices over the forecast period.

The Global intra-abdominal pressure measurement devices market is estimated to be valued at US$ 106.7 Mn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030.

Key Takeaways

Key players operating in the intra-abdominal pressure measurement devices are CR. Bard, Inc. (Becton, Dickinson, and Company), ConvaTec Group PLC, Stryker Corporation, Biometrix Ltd. (Degania Silicone, Ltd.), Centurion Medical Products (Medline Industries, Inc.), and Potrero Medical. These players are focusing on new product launches and strategic collaborations to increase their market share.

The intra-abdominal pressure measurement devices market provides significant opportunities with growing critical care needs in developing economies. Market players are expanding their manufacturing and distribution facilities in Asia Pacific and Latin America to tap the increasing demand from these regions.

Rising burden of chronic diseases such as cancer, neurological disorders and cardiovascular diseases globally is fueling the demand for critical care therapies. This is anticipated to drive the global expansion of key players in the intra-abdominal pressure measurement devices market through 2030.

Market drivers

One of the key drivers for the intra-abdominal pressure measurement devices market's growth is the rising incidence of sepsis across the globe. Sepsis is a life-threatening condition that arises when the body's response to infection causes injury to its own tissues and organs. According to the Centers for Disease Control and Prevention, around 1.7 million adults in the US develop sepsis each year, resulting in around 270,000 deaths. Intra-abdominal pressure monitoring is crucial in managing sepsis and its related complications, such as abdominal compartment syndrome.

Market restraints

A major challenge hampering the intra-abdominal pressure measurement devices market expansion is the lack of clinical evidence demonstrating improved patient outcomes with pressure monitoring. Although intra-abdominal hypertension is associated with several comorbidities, there is a lack of high-quality studies evaluating whether pressure monitoring leads to decreased healthcare costs or improved survival. This has resulted in low clinical routine use of these devices in some regions, restricting market growth.

Segment Analysis
The bladder pressure measurement segment dominates the intra-abdominal pressure measurement devices market. This segment holds the largest revenue share as intravesical pressure measurement through Foley catheters is the gold standard method for intra-abdominal pressure (IAP) monitoring. Intestinal gas pressure measurement is the fastest growing segment due to the growing adoption of endogastric pressure monitoring through nasogastric tubes or enterostomy silicone tubes for critically ill patients in intensive care units.

Global Analysis
North America dominates the intra-abdominal pressure measurement devices market due to strong regional presence of key players, rising incidence of abdominal complications among the geriatric population, increasing adoption of minimally invasive surgeries, and superior healthcare infrastructure. Asia Pacific is predicted to witness the highest growth rate over the forecast period owing to surging healthcare expenditure, growing patient awareness regarding IAP monitoring, and expanding medical tourism industry in countries such as India, China, and Japan.